Physician profile
Danny Wang
NPI 1619962578
$6,447.73
in general payments reported to CMS, 2019-2025
34 companies · $897 in 2025
The $897 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $688 · 2020: $749 · 2021: $1,130 · 2022: $1,105 · 2023: $826 · 2024: $1,052 · 2025: $897.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,775.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,774.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $820.99 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $627.78 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $562.73 | 2019-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $550.32 | 2021-2025 | Verquvo |
| Astrazeneca Pharmaceuticals Lp | $491.69 | 2019-2025 | Wainua |
| Pfizer INC. | $462.26 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $434.75 | 2019-2025 | Jardiance |
| Amarin Pharma, INC. | $417.48 | 2019-2022 | |
| Amgen INC. | $244.60 | 2020-2025 | Repatha, Repatha |
| Irhythm Technologies, INC. | $243.12 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Esperion Therapeutics, INC. | $188.06 | 2020-2025 | Nexletol |
| W. L. Gore & Associates, INC. | $176.42 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $155.43 | 2021-2025 | Lifevest |
| Abbott Laboratories | $132.96 | 2019-2025 | Jot Dx |
| Novo Nordisk INC | $106.93 | 2019-2025 | Wegovy |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $99.21 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $93.74 | 2021-2025 | |
| Daiichi Sankyo INC. | $93.09 | 2021-2023 | Injectafer |
| Philips North America LLC | $70.72 | 2023-2024 | (Ck7) Extended Holter, (Ck4) Mcot |
| Scpharmaceuticals INC. | $68.81 | 2024-2025 | |
| Heartflow, INC. | $63.35 | 2024-2025 | |
| Lexicon Pharmaceuticals, INC. | $62.57 | 2023-2024 | Inpefa |
| Balt USA, LLC | $36.52 | 2024 | Prestige Coil System |
| Kiniksa Pharmaceuticals International, Plc | $32.94 | 2024 | Arcalyst |
| Medtronic Vascular, INC. | $30.87 | 2019 | |
| Edwards Lifesciences Corporation | $27.36 | 2019 | |
| Baxter Healthcare | $25.20 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Atricure, INC. | $24.61 | 2024 | |
| Genzyme Corporation | $22.88 | 2024 | |
| Exact Sciences Corporation | $19.90 | 2025 | Cologuard Collection Kit |
| Bridgebio Pharma, INC. | $16.77 | 2025 | Attruby |
| Kiniksa Pharmaceuticals, Ltd. | $15.16 | 2023 | Arcalyst |
| Biotronik INC. | $14.69 | 2019 | |
| Kestra Medical Technology Services, INC. | $13.82 | 2025 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danny Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.